PRCT
PROCEPT BioRobotics·NASDAQ
--
--(--)
--
--(--)
5.27 / 10
Netural
With a fund flow rating of 7.75/10, the stock shows robust fund flow characteristics. Supportive momentum from no significant trends trends is partially offset by concerning overall, block, Small, Medium, Large, and Extra-large patterns, pointing to positive capital flow trajectory. Research analyst consensus shows overwhelmingly bullish analyst consensus, demonstrating strong conviction. Current ratings: Strong Buy(50.0%), Buy(25.0%), Neutral(25.0%) across 4 coverage providers, supported by 2.79 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
25%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-08
InstitutionB of A Securities
Times predicted2
Historical Win Rate100.0%
What is the analyst consensus for PRCT?
- PRCT holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.27/10 (Netural).
